Past and current perspective on new therapeutic targets for Type-II diabetes

Patil, PD; Mahajan, UB; Patil, KR; Chaudhari, S; Patil, CR; Agrawal, YO; Ojha, S; Goyal, SN

Ojha, S (reprint author), United Arab Emirates Univ, Coll Med & Hlth Sci, Dept Pharmacol & Therapeut, POB 17666, Abu Dhabi, U Arab Emirates.

DRUG DESIGN DEVELOPMENT AND THERAPY, 2017; 11 ( ): 1567

Abstract

Loss of pancreatic beta-cell function is a hallmark of Type-II diabetes mellitus (DM). It is a chronic metabolic disorder that results from defects in......

Full Text Link